Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8208)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2015 (publication date) through Jan 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tian SB, Yu JC, Liu YQ, Kang WM, Ma ZQ, Ye X, Yan C. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World J Gastroenterol 2015; 21(31): 9337-9347 [PMID: 26309359 DOI: 10.3748/wjg.v21.i31.9337] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i31/9337.htm |
| Number | Citing Articles |
| 1 |
Lingyun Xu, Chen Li. Single-Cell Transcriptome Analysis Reveals the M2 Macrophages and Exhausted T
Cells and Intratumoral Heterogeneity in Triple-Negative Breast Cancer. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(2): 294 doi: 10.2174/1871520621666210618100857
|
| 2 |
Zhen-Jie Fu, Yan Chen, Yu-Qin Xu, Mei-Ai Lin, Hang Wen, Yi-Tao Chen, Pei-Lei Pan. Regulation of miR-30b in cancer development, apoptosis, and drug resistance. Open Life Sciences 2022; 17(1): 102 doi: 10.1515/biol-2022-0017
|
| 3 |
Cheng Chen, Bojia Zhang, Shanshan Wu, Yongxiang Song, Jian Li. Knockdown of EIF5A2 inhibits the malignant potential of non-small cell lung cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.7832
|
| 4 |
Chunduo Zhang, Xiang Pan, Xiqi Peng, Kaihao Liu, Jingyao Wang, Liwen Zhao, Xuan Chen, Guocheng Huang, Hang Li, Jing Ye, Yongqing Lai. miR‐30b‐5p up‐regulation related to the dismal prognosis for patients with renal cell cancer. Journal of Clinical Laboratory Analysis 2021; 35(2) doi: 10.1002/jcla.23599
|
| 5 |
A. Adam-Artigues, I. Garrido-Cano, S. Simón, B. Ortega, S. Moragón, A. Lameirinhas, V. Constâncio, S. Salta, O. Burgués, B. Bermejo, R. Henrique, A. Lluch, C. Jerónimo, P. Eroles, J.M. Cejalvo. Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer. ESMO Open 2021; 6(1): 100039 doi: 10.1016/j.esmoop.2020.100039
|
| 6 |
Xinyan Wang, Yifei Jin, Hui Zhang, Xinyu Huang, Yuanhui Zhang, Jianwei Zhu. MicroRNA-599 inhibits metastasis and epithelial-mesenchymal transition via targeting EIF5A2 in gastric cancer. Biomedicine & Pharmacotherapy 2018; 97: 473 doi: 10.1016/j.biopha.2017.10.069
|
| 7 |
Xiaolin Sun, Shuhua Zhao, Huanan Li, Hanwen Chang, Zhen Huang, Zhi Ding, Lei Dong, Jiangning Chen, Yuhui Zang, Junfeng Zhang. MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells. Journal of Cellular Physiology 2017; 232(3): 625 doi: 10.1002/jcp.25466
|
| 8 |
Gao-Qi Wu, Yan-Ming Xu, Andy T. Y. Lau. Recent insights into eukaryotic translation initiation factors 5A1 and 5A2 and their roles in human health and disease. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01226-7
|
| 9 |
Rosa Murria Estal, Blanca de Unamuno Bustos, Gema Pérez Simó, Javier Simarro Farinos, Ignacio Torres Navarro, Victor Alegre de Miquel, Rosa Ballester Sánchez, Vicente Sabater Marco, Margarita Llavador Ros, Sarai Palanca Suela, Rafael Botella Estrada. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas. Melanoma Research 2021; 31(1): 18 doi: 10.1097/CMR.0000000000000709
|
| 10 |
Guillermo Nicolás Dalton, Cintia Massillo, Georgina Daniela Scalise, Rocío Duca, Juliana Porretti, Paula Lucia Farré, Kevin Gardner, Alejandra Paez, Geraldine Gueron, Paola De Luca, Adriana De Siervi. CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice. Cell Death & Disease 2019; 10(4) doi: 10.1038/s41419-019-1535-z
|
| 11 |
Lu Jin, Yifan Li, Tao He, Jia Hu, Jiaju Liu, Mingwei Chen, Min Shi, Zhimao Jiang, Shangqi Yang, Xiangming Mao, Yaoting Gui, Yongqing Lai. Identification of miR-30b as an oncogene in renal cell carcinoma. Molecular Medicine Reports 2017; 15(4): 1837 doi: 10.3892/mmr.2017.6197
|
| 12 |
Xiu-Yan Li, Yu-Ting Luo, Yan-Hong Wang, Zhi-Xin Yang, Yu-Zhou Shang, Qing-Xia Guan. Anti-inflammatory effect and antihepatoma mechanism of carrimycin. World Journal of Gastroenterology 2023; 29(14): 2134-2152 doi: 10.3748/wjg.v29.i14.2134
|
| 13 |
Zhiqian Liu, Xiaoqing Wei, Aiqun Zhang, Chonghui Li, Jia Bai, Jiahong Dong. Long non-coding RNA HNF1A-AS1 functioned as an oncogene and autophagy promoter in hepatocellular carcinoma through sponging hsa-miR-30b-5p. Biochemical and Biophysical Research Communications 2016; 473(4): 1268 doi: 10.1016/j.bbrc.2016.04.054
|
| 14 |
Yanhui Liu, Fei Xue, Yin Zhang, Pingchong Lei, Zhen Wang, Zunmin Zhu, Kai Sun. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation. Anti-Cancer Drugs 2017; 28(10): 1097 doi: 10.1097/CAD.0000000000000550
|
| 15 |
Fan Zhang, Ying Li, Weiran Xu, Liang He, Yan Tan, Hong Xu. Long non-coding RNA ZFAS1 regulates the malignant progression of gastric cancer via the microRNA-200b-3p/Wnt1 axis. Bioscience, Biotechnology, and Biochemistry 2019; 83(7): 1289 doi: 10.1080/09168451.2019.1606697
|
| 16 |
Yi-Lin Zhong, Peng-Qian Wang, Dan-Li Hao, Feng Sui, Feng-Bin Zhang, Bing Li. Traditional Chinese medicine for transformation of gastric precancerous lesions to gastric cancer: A critical review. World Journal of Gastrointestinal Oncology 2023; 15(1): 36-54 doi: 10.4251/wjgo.v15.i1.36
|
| 17 |
Swalih P. Ahmed, Mehdi H. Shahi. miR-30b-5p Promotes Medulloblastoma Cell Proliferation by Regulating Stem Cell Factors NANOG, BMI1, Tumor Suppressor Gene P53 and the Shh-Gli1 Pathway. Indian Journal of Clinical Biochemistry 2024; doi: 10.1007/s12291-024-01274-0
|
| 18 |
Yan Li, Jinhua Zhou, Juan Wang, Xiaoping Chen, Yan Zhu, Youguo Chen. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene. Biological Research 2020; 53(1) doi: 10.1186/s40659-020-00277-4
|
| 19 |
Qing Li, Xuan Zhang, Ning Li, Qin Liu, Dongfeng Chen. miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer. Biochemical and Biophysical Research Communications 2017; 485(2): 506 doi: 10.1016/j.bbrc.2017.02.016
|
| 20 |
Zhiqing Duan, Lu Li, Yan Li. Involvement of miR-30b in kynurenine-mediated lysyl oxidase expression. Journal of Physiology and Biochemistry 2019; 75(2): 135 doi: 10.1007/s13105-019-00686-4
|
| 21 |
Francesca Varrone, Emilia Caputo. The miRNAs Role in Melanoma and in Its Resistance to Therapy. International Journal of Molecular Sciences 2020; 21(3): 878 doi: 10.3390/ijms21030878
|
| 22 |
Jimin Min, Tae-Su Han, Yoojin Sohn, Takahiro Shimizu, Boram Choi, Seong-Woo Bae, Keun Hur, Seong-Ho Kong, Yun-Suhk Suh, Hyuk-Joon Lee, Jang-Seong Kim, Jeong-Ki Min, Woo-Ho Kim, V. Narry Kim, Eunyoung Choi, James R. Goldenring, Han-Kwang Yang. microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2. Gastric Cancer 2020; 23(4): 600 doi: 10.1007/s10120-020-01052-w
|
| 23 |
Yongyi Chen, Jie Zhang, Wangang Gong, Wumin Dai, Xiaohong Xu, Songxiao Xu. miR-588 is a prognostic marker in gastric cancer. Aging 2021; 13(2): 2101 doi: 10.18632/aging.202212
|
| 24 |
Tianqi Wu, Hongming Song, Dan Xie, Kaiyao Hua, Jiashu Hu, Yijun Deng, Changle Ji, Lin Fang, Sun-On Chan. Mir‐30b‐5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/7907269
|
| 25 |
Changpu Zhao, Zhongqin Dang, Junbo Sun, Shuaiqiang Yuan, Li Xie. Up‐regulation of microRNA‐30b/30d cluster represses hepatocyte apoptosis in mice with fulminant hepatic failure by inhibiting CEACAM1. IUBMB Life 2020; 72(7): 1349 doi: 10.1002/iub.2256
|
| 26 |
Lin Jiang, Yingjing Zhang, Pengfei Su, Zhiqiang Ma, Xin Ye, Weiming Kang, Yuqin Liu, Jianchun Yu. Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p/EIF5A2 pathway. Translational Oncology 2022; 18: 101351 doi: 10.1016/j.tranon.2022.101351
|
| 27 |
Qiaoling Pan, Lebo Sun, Dawei Zheng, Ni Li, Huoshun Shi, Jie Song, Guofeng Shao, Guodong Xu. MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/1769040
|
| 28 |
Shimin Zhuang, Jing Xie, Jing Zhen, Liangyun Guo, Zhengdong Hong, Feihong Li, Debin Xu. The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2. Molecular and Cellular Endocrinology 2021; 537: 111440 doi: 10.1016/j.mce.2021.111440
|
| 29 |
Dan Lou, Qiaojing Jia, Haizhong Zhang, Jingmiao Wang, Lisha Liu, Zhichang Liu, Xiaofang Jia, Jianxing Wang, Chunguang Shan. MiR-5189-3p Suppresses cell Proliferation, Invasion and Migration Through Targeting EIF5A2 in Laryngeal Squamous Cell Carcinoma. Biochemical Genetics 2024; 62(3): 1603 doi: 10.1007/s10528-023-10489-4
|
| 30 |
Zhi-Qing Duan, Yan Li, Lu Li. Experimental evidences for miR-30b as a negative regulator of FOXO3 upregulated by kynurenine. Immunologic Research 2017; 65(5): 1074 doi: 10.1007/s12026-017-8949-4
|
| 31 |
Wei Chen, Yuye Huang, Shufen Zhang, Xiaoxiao Zheng, Shangzhi Xie, Jiayan Mao, Ying Cai, Xuemei Lu, Liqiang Hu, Jian Shen, Ying Dong, Kequn Chai. MicroRNA‐212 suppresses nonsmall lung cancer invasion and migration by regulating ubiquitin‐specific protease‐9. Journal of Cellular Biochemistry 2019; 120(4): 6482 doi: 10.1002/jcb.27939
|
| 32 |
V. Vaira, C. Verdelli, I. Forno, S. Corbetta. MicroRNAs in parathyroid physiopathology. Molecular and Cellular Endocrinology 2017; 456: 9 doi: 10.1016/j.mce.2016.10.035
|
| 33 |
Xiaoqing Guan, Shucheng Gu, Mu Yuan, Xiangxin Zheng, Ji Wu. MicroRNA‑33a‑5p overexpression sensitizes triple‑negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial‑mesenchymal transition. Oncology Letters 2019; doi: 10.3892/ol.2019.10984
|
| 34 |
Wenjun Xu, Zhenjie Fu, Yuqin Xu, Man Hei Cheung, Yan Chen, Meiai Lin, Hang Wen, Hang Lv, Chun Liang, Jianshu Lou, Yitao Chen. pPe <italic>O</italic>p inhibits HGC-27 cell proliferation, migration and invasion by upregulating miR-30b-5p and down-regulating the Rac1/Cdc42 pathway. Acta Biochimica et Biophysica Sinica 2022; 54(12): 1897 doi: 10.3724/abbs.2022193
|
| 35 |
Qing-Bin Meng, Jing-Jing Peng, Zi-Wei Qu, Xiao-Min Zhu, Zhang Wen, Wei-Ming Kang. Eukaryotic initiation factor 5A2 and human digestive system neoplasms. World Journal of Gastrointestinal Oncology 2019; 11(6): 449-458 doi: 10.4251/wjgo.v11.i6.449
|
| 36 |
Chengyan Xu, Zixia He, Chao Lin, Zhipeng Shen. Mir-30B-5P Inhibits Proliferation and Promotes Apoptosis of Medulloblastoma Cells via Targeting Myb Proto-Oncogene like 2 (Mybl2). Journal of Investigative Medicine 2020; 68(6): 1179 doi: 10.1136/jim-2020-001354
|